Inhibition of catechol-O-methyltransferase activity by two novel disubstituted catechols in the rat.

PubWeight™: 1.09‹?› | Rank: Top 10%

🔗 View Article (PMID 3181288)

Published in Eur J Pharmacol on August 24, 1988

Authors

E Nissinen1, I B Lindén, E Schultz, S Kaakkola, P T Männistö, P Pohto

Author Affiliations

1: Orion Pharmaceutica, Research Center, Espoo, Finland.

Articles citing this

An endogenous capsaicin-like substance with high potency at recombinant and native vanilloid VR1 receptors. Proc Natl Acad Sci U S A (2002) 3.16

Different in vivo properties of three new inhibitors of catechol O-methyltransferase in the rat. Br J Pharmacol (1992) 1.02

Effect of entacapone, a peripherally acting catechol-O-methyltransferase inhibitor, on the motor response to acute treatment with levodopa in patients with Parkinson's disease. J Neurol Neurosurg Psychiatry (1994) 0.96

Inhibitors of catechol-O-methyltransferase sensitize mice to pain. Br J Pharmacol (2010) 0.79

COMT inhibition with nitecapone does not affect the tyramine pressor response. Br J Clin Pharmacol (1991) 0.79

Effect of monoamine oxidase A and B and of catechol-O-methyltransferase inhibition on L-DOPA-induced circling behavior. J Neural Transm (Vienna) (1997) 0.79

Pharmacological profile of opicapone, a third-generation nitrocatechol catechol-O-methyl transferase inhibitor, in the rat. Br J Pharmacol (2015) 0.79

Organic cation transporter mRNA and function in the rat superior cervical ganglion. J Physiol (2002) 0.78

The effects of the COMT inhibitor entacapone on haemodynamics and peripheral catecholamine metabolism during exercise. Br J Clin Pharmacol (1993) 0.78

Peripheral and central inhibitors of catechol-O-methyl transferase: effects on liver and brain COMT activity and L-DOPA metabolism. J Neural Transm (Vienna) (1997) 0.77

In vivo effects of new inhibitors of catechol-O-methyl transferase. Br J Pharmacol (1999) 0.76

Catechol-O-methyltransferase inhibition alters pain and anxiety-related volitional behaviors through activation of β-adrenergic receptors in the rat. Neuroscience (2015) 0.76

Articles by these authors

Catechol-O-methyltransferase (COMT): biochemistry, molecular biology, pharmacology, and clinical efficacy of the new selective COMT inhibitors. Pharmacol Rev (1999) 3.81

Satellite cells are mitotically quiescent in mature mouse muscle: an EM and radioautographic study. J Exp Zool (1978) 1.99

Reassortment of pilin genes in Neisseria gonorrhoeae occurs by two distinct mechanisms. Nature (1989) 1.98

POLG mutations in neurodegenerative disorders with ataxia but no muscle involvement. Neurology (2004) 1.89

Skeletal muscle satellite cells: changes in proliferation potential as a function of age. Mech Ageing Dev (1982) 1.75

Response of satellite cells to focal skeletal muscle injury. Muscle Nerve (1985) 1.73

Diagnosis and clinical characteristics of ocular Lyme borreliosis. Am J Ophthalmol (1995) 1.65

A double blind, randomised, parallel group study to investigate the dose equivalence of Dysport and Botox in the treatment of cervical dystonia. J Neurol Neurosurg Psychiatry (1998) 1.60

Age-related differences in absolute numbers of skeletal muscle satellite cells. Muscle Nerve (1983) 1.51

Comparative liver toxicity of various erythromycin derivatives in animals. J Antimicrob Chemother (1988) 1.41

On the role of prolyl oligopeptidase in health and disease. Neuropeptides (2006) 1.39

Studies on cardiac myofibrillogenesis with antibodies to titin, actin, tropomyosin, and myosin. J Cell Biol (1988) 1.38

Cardiac troponin C as a target protein for a novel calcium sensitizing drug, levosimendan. J Mol Cell Cardiol (1995) 1.33

Impairing effect of food on ketoconazole absorption. Antimicrob Agents Chemother (1982) 1.32

Generation of capsule-deficient Neisseria meningitidis strains by homologous recombination. Mol Microbiol (1990) 1.29

Laminin is induced in astrocytes of adult brain by injury. EMBO J (1984) 1.28

Comparative pharmacokinetics of metronidazole and tinidazole as influenced by administration route. Antimicrob Agents Chemother (1983) 1.24

Haem arginate: a new stable haem compound. J Pharm Pharmacol (1987) 1.21

Adrenergic innervation and structure of the bull retractor penis muscle. Acta Physiol Scand (1970) 1.21

Hindlimb suspension suppresses muscle growth and satellite cell proliferation. J Appl Physiol (1985) (1989) 1.20

Drug-resistant pulmonary tuberculosis in the Baja California-San Diego County border population. West J Med (1998) 1.14

Exercise-induced satellite cell activation in growing and mature skeletal muscle. J Appl Physiol (1985) (1987) 1.14

Developmental fate of skeletal muscle satellite cells. Science (1979) 1.13

Troponin C-mediated calcium sensitization induced by levosimendan does not impair relaxation. J Cardiovasc Pharmacol (1995) 1.12

Synthesis of some novel potent and selective catechol O-methyltransferase inhibitors. J Med Chem (1989) 1.12

Identification of five MAGE-A1 epitopes recognized by cytolytic T lymphocytes obtained by in vitro stimulation with dendritic cells transduced with MAGE-A1. J Immunol (1999) 1.11

Economic burden and quality of life impairment increase with severity of PD. Parkinsonism Relat Disord (2003) 1.11

Release of biologically active CD154 during collection and storage of platelet concentrates prepared for transfusion. J Thromb Haemost (2007) 1.10

Comparison of body composition by bioelectrical impedance analysis and dual-energy X-ray absorptiometry in Hispanic diabetics. Int J Body Compos Res (2010) 1.07

Effects of skeletal muscle regeneration on the proliferation potential of satellite cells. Mech Ageing Dev (1985) 1.05

Rationale for selective COMT inhibitors as adjuncts in the drug treatment of Parkinson's disease. Pharmacol Toxicol (1990) 1.04

Bone density of the radius, spine, and proximal femur in osteoporosis. J Bone Miner Res (1988) 1.04

Clinical and genetic findings in Finnish ataxia patients with the spinocerebellar ataxia 8 repeat expansion. Ann Neurol (2000) 1.03

Biochemical and pharmacological properties of a peripherally acting catechol-O-methyltransferase inhibitor entacapone. Naunyn Schmiedebergs Arch Pharmacol (1992) 1.03

Fine structure of satellite cells in growing skeletal muscle. Am J Anat (1976) 1.03

An anatomic study of the rat larynx: establishing the rat model for neuromuscular function. Otolaryngol Head Neck Surg (1998) 1.02

The distribution of satellite cells and their relationship to specific fiber types in soleus and extensor digitorum longus muscles. Anat Rec (1982) 1.01

New oxygenases in the degradation of flavones and flavanones by Pseudomonas putida. Biochemistry (1974) 1.00

Parkin interacts with the proteasome subunit alpha4. FEBS Lett (2005) 0.99

Effect of lithium and rubidium on the sleeping time caused by various intravenous anaesthetics in the mouse. Br J Anaesth (1976) 0.97

Myogenin, MyoD, and myosin expression after pharmacologically and surgically induced hypertrophy. J Appl Physiol (1985) (1998) 0.97

Pharmacokinetics of nalidixinic acid and oxolinic acid in healthy women. Clin Pharmacol Ther (1976) 0.97

Catechol O-methyltransferase inhibitor tolcapone has minor influence on performance in experimental memory models in rats. Behav Brain Res (1997) 0.97

Effects of haloperidol on selective attention: a combined whole-head MEG and high-resolution EEG study. Neuropsychopharmacology (2001) 0.96

Absence of exogenous satellite cell contribution to regeneration of frozen skeletal muscle. J Muscle Res Cell Motil (1986) 0.96

Improved assay of reaction products to quantitate catechol-O-methyltransferase activity by high-performance liquid chromatography with electrochemical detection. J Chromatogr B Biomed Appl (1995) 0.96

Characteristics of catechol O-methyl-transferase (COMT) and properties of selective COMT inhibitors. Prog Drug Res (1992) 0.96

New selective COMT inhibitors: useful adjuncts for Parkinson's disease? Trends Pharmacol Sci (1989) 0.96

7-Nitroindazole, a nitric oxide synthase inhibitor, has anxiolytic-like properties in exploratory models of anxiety. Psychopharmacology (Berl) (1997) 0.95

The role of cAMP- and cGMP-dependent protein kinases in the cardiac actions of the new calcium sensitizer, levosimendan. Cardiovasc Res (1997) 0.95

Muscle regeneration during hindlimb unloading results in a reduction in muscle size after reloading. J Appl Physiol (1985) (2001) 0.94

Changes in the satellite cells of growing muscle following denervation. Anat Rec (1978) 0.94

Potassium supplementation in blacks with mild to moderate essential hypertension. J Hypertens (1986) 0.93

Unloading of juvenile muscle results in a reduced muscle size 9 wk after reloading. J Appl Physiol (1985) (2000) 0.93

The effect of Marcaine on muscle and non-muscle cells in vitro. Anat Rec (1978) 0.93

A quantitative study of the satellite cell population in postnatal mouse lumbrical muscle. Anat Rec (1974) 0.92

Structural properties of the subscapularis tendon. J Orthop Res (2000) 0.92

A prolyl oligopeptidase inhibitor, KYP-2047, reduces α-synuclein protein levels and aggregates in cellular and animal models of Parkinson's disease. Br J Pharmacol (2012) 0.92

Catecholamine metabolism in the brain by membrane-bound and soluble catechol-o-methyltransferase (COMT) estimated by enzyme kinetic values. Med Hypotheses (2001) 0.91

Entacapone, a novel catechol-O-methyltransferase inhibitor for Parkinson's disease, does not impair mitochondrial energy production. Eur J Pharmacol (1997) 0.91

A battery of toxicity tests as indicators of decontamination in composting oily waste. Ecotoxicol Environ Saf (2000) 0.91

Activation of 5-HT2A receptors impairs response control of rats in a five-choice serial reaction time task. Neuropharmacology (2000) 0.91

Chicken cardiac myofibrillogenesis studied with antibodies specific for titin and the muscle and nonmuscle isoforms of actin and tropomyosin. Cell Tissue Res (1991) 0.91

General properties and clinical possibilities of new selective inhibitors of catechol O-methyltransferase. Gen Pharmacol (1994) 0.91

Absorption of erythromycin acistrate and erythromycin base in the fasting and non-fasting state. J Antimicrob Chemother (1988) 0.91

Exercise hemodynamics and catecholamine metabolism after catechol-O-methyltransferase inhibition with nitecapone. Clin Pharmacol Ther (1990) 0.91

Prolyl oligopeptidase induces angiogenesis both in vitro and in vivo in a novel regulatory manner. Br J Pharmacol (2011) 0.91

Dietary creatine monohydrate supplementation increases satellite cell mitotic activity during compensatory hypertrophy. Int J Sports Med (2000) 0.91

Suppression of transient 40-Hz auditory response by haloperidol suggests modulation of human selective attention by dopamine D2 receptors. Neurosci Lett (2000) 0.91

The effect of an increased ratio of carbidopa to levodopa on the pharmacokinetics of levodopa. Acta Neurol Scand (1985) 0.90

Fan-beam computerized tomography systems with rotating and with stationary detector arrays ('third' and 'fourth' generation). Med Prog Technol (1980) 0.90

[Phantom measurements of spatial resolution and the partial-volume-effect in computer tomography (author's transl)]. Rofo (1978) 0.89

How useful is [123I]beta-CIT SPECT in clinical practice? J Neurol Neurosurg Psychiatry (2005) 0.89

Scapulothoracic dissociation. Am J Orthop (Belle Mead NJ) (1998) 0.88

Effect of entacapone, a COMT inhibitor, on the pharmacokinetics and metabolism of levodopa after administration of controlled-release levodopa-carbidopa in volunteers. Clin Neuropharmacol (1995) 0.88

Striatal membrane-bound and soluble catechol-O-methyl-transferase after selective neuronal lesions in the rat. J Neural Transm (1987) 0.88

Modulation of histamine H3 receptors in the brain of 6-hydroxydopamine-lesioned rats. Eur J Neurosci (2000) 0.88

Impairment of captopril bioavailability by concomitant food and antacid intake. Int J Clin Pharmacol Ther Toxicol (1984) 0.88

Properties of novel effective and highly selective inhibitors of catechol-O-methyltransferase. Life Sci (1988) 0.88

Effect of carbenoxolone on phosphodiesterase and prostaglandin synthetase activities. Experientia (1978) 0.88

Catechol-O-methyltransferase activity in human and rat small intestine. Life Sci (1988) 0.87

Effect of tolcapone, a catechol-O-methyltransferase inhibitor, on striatal dopaminergic transmission during blockade of dopamine uptake. Eur J Pharmacol (1999) 0.87

L-dopa induces dyskinesia in normal monkeys: behavioural and pharmacokinetic observations. Psychopharmacology (Berl) (2001) 0.87

Expression and traffic of cellular prolyl oligopeptidase are regulated during cerebellar granule cell differentiation, maturation, and aging. Neuroscience (2008) 0.87

Effects of two erythromycins, doxycycline and phenoxymethylpenicillin on human leucocyte chemotaxis in vitro. J Antimicrob Chemother (1988) 0.86

Computerized rotometer apparatus for recording circling behavior. Methods Find Exp Clin Pharmacol (1989) 0.86

Hyperplasia of jejunal smooth muscle in the myenterically denervated rat. Cell Tissue Res (1988) 0.86

Dystrophin expression improves myofiber survival in mdx muscle following intramuscular plasmid DNA injection. Hum Mol Genet (1993) 0.86

Skeletal muscle myofibrillogenesis as revealed with a monoclonal antibody to titin in combination with detection of the alpha- and gamma-isoforms of actin. Dev Biol (1989) 0.86

Sonography of patellar abnormalities in children. AJR Am J Roentgenol (1998) 0.86

Inhibition of soluble catechol-O-methyltransferase and single-dose pharmacokinetics after oral and intravenous administration of entacapone. Eur J Clin Pharmacol (1994) 0.85